BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue JT, Riddell MC, Burdett E, Coy DH, Efendic S, Vranic M. Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats. Diabetes 2013;62:2215-22. [PMID: 23434929 DOI: 10.2337/db12-1523] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Farhy LS, Mccall AL. Glucagon – the new ‘insulin’ in the pathophysiology of diabetes: . Current Opinion in Clinical Nutrition and Metabolic Care 2015;18:407-14. [DOI: 10.1097/mco.0000000000000192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
2 Huang H, Bader TN, Jin S. Signaling Molecules Regulating Pancreatic Endocrine Development from Pluripotent Stem Cell Differentiation. Int J Mol Sci 2020;21:E5867. [PMID: 32824212 DOI: 10.3390/ijms21165867] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Taleb N, Rabasa-Lhoret R. Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes? Diabetologia 2016;59:1632-5. [PMID: 27153841 DOI: 10.1007/s00125-016-3978-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hoffman EG, Jahangiriesmaili M, Mandel ER, Greenberg C, Aiken J, D'Souza NC, Pasieka A, Teich T, Chan O, Liggins R, Riddell MC. Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats. Endocrinology 2021;162:bqab189. [PMID: 34477204 DOI: 10.1210/endocr/bqab189] [Reference Citation Analysis]
5 GhavamiNejad A, Lu B, Samarikhalaj M, Liu JF, Mirzaie S, Pereira S, Zhou L, Giacca A, Wu XY. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. Drug Deliv Transl Res 2021. [PMID: 33683625 DOI: 10.1007/s13346-021-00944-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Leclair E, Liggins RT, Peckett AJ, Teich T, Coy DH, Vranic M, Riddell MC. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes. Diabetologia 2016;59:1724-31. [PMID: 27075449 DOI: 10.1007/s00125-016-3953-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gaisano HY, Macdonald PE, Vranic M. Glucagon secretion and signaling in the development of diabetes. Front Physiol 2012;3:349. [PMID: 22969729 DOI: 10.3389/fphys.2012.00349] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
8 Müller TD, Finan B, Clemmensen C, DiMarchi RD, Tschöp MH. The New Biology and Pharmacology of Glucagon. Physiol Rev 2017;97:721-66. [PMID: 28275047 DOI: 10.1152/physrev.00025.2016] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 24.2] [Reference Citation Analysis]
9 Xu SFS, Andersen DB, Izarzugaza JMG, Kuhre RE, Holst JJ. In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose‐induced inhibition of glucagon secretion. Acta Physiol 2020;229. [DOI: 10.1111/apha.13464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
10 Campbell JE, Drucker DJ. Islet α cells and glucagon--critical regulators of energy homeostasis. Nat Rev Endocrinol. 2015;11:329-338. [PMID: 25850661 DOI: 10.1038/nrendo.2015.51] [Cited by in Crossref: 144] [Cited by in F6Publishing: 130] [Article Influence: 20.6] [Reference Citation Analysis]
11 Svendsen B, Holst JJ. Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets. Diabetologia 2021;64:142-51. [PMID: 33043402 DOI: 10.1007/s00125-020-05288-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Gao R, Yang T, Zhang Q. δ-Cells: The Neighborhood Watch in the Islet Community. Biology (Basel) 2021;10:74. [PMID: 33494193 DOI: 10.3390/biology10020074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Monnerat-Cahli G, Trentin-Sonoda M, Guerra B, Manso G, Ferreira AC, Silva DL, Coutinho DC, Carneiro-Ramos MS, Rodrigues DC, Cabral-da-Silva MC. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats. Int J Cardiol. 2014;171:199-208. [PMID: 24374203 DOI: 10.1016/j.ijcard.2013.12.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Miranda C, Begum M, Vergari E, Briant LJB. Gap junction coupling and islet delta-cell function in health and disease. Peptides 2021;147:170704. [PMID: 34826505 DOI: 10.1016/j.peptides.2021.170704] [Reference Citation Analysis]
15 Ng XW, Chung YH, Piston DW. Intercellular Communication in the Islet of Langerhans in Health and Disease. Compr Physiol 2021;11:2191-225. [PMID: 34190340 DOI: 10.1002/cphy.c200026] [Reference Citation Analysis]
16 Cherrington A, Rashid S. Dr. Mladen Vranic-A Legend in Diabetes Research: 1930-2019. Diabetes Care 2020;43:1997-2000. [PMID: 32703766 DOI: 10.2337/dci20-0010] [Reference Citation Analysis]
17 Rorsman P, Huising MO. The somatostatin-secreting pancreatic δ-cell in health and disease. Nat Rev Endocrinol 2018;14:404-14. [PMID: 29773871 DOI: 10.1038/s41574-018-0020-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 23.7] [Reference Citation Analysis]
18 Krentz NAJ, Shea LD, Huising MO, Shaw JAM. Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering. Lancet Diabetes Endocrinol 2021;9:708-24. [PMID: 34480875 DOI: 10.1016/S2213-8587(21)00170-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Farhat R, de Santana-Van Vliet E, Su G, Neely L, Benally T, Chan O. Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats. Endocrinol Diabetes Metab 2021;4:e00226. [PMID: 33855225 DOI: 10.1002/edm2.226] [Reference Citation Analysis]
20 Huising MO. Paracrine regulation of insulin secretion. Diabetologia 2020;63:2057-63. [PMID: 32894316 DOI: 10.1007/s00125-020-05213-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Moser O, Yardley JE, Bracken RM. Interstitial Glucose and Physical Exercise in Type 1 Diabetes: Integrative Physiology, Technology, and the Gap In-Between. Nutrients. 2018;10. [PMID: 29342932 DOI: 10.3390/nu10010093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
22 Karimian N, Qin T, Liang T, Osundiji M, Huang Y, Teich T, Riddell MC, Cattral MS, Coy DH, Vranic M, Gaisano HY. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats. Diabetes 2013;62:2968-77. [PMID: 23630299 DOI: 10.2337/db13-0164] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]